Preparations and formulations for phage therapy

8 September 2021

T. Briot (Lyon, France)

Rapid spread of antibiotic resistance is a serious threat to human healthcare for the upcoming years. Phage therapy consists in delivering viruses able to infect and kill bacteria, namely bacteriophages. They have a synergistic anti-biofilm activity with antibiotics and thus represent a promising and complementary therapeutic approach to treat infections due to multidrug-resistant bacteria. Moreover, phage therapy is a highly personalized strategy because of the specific activity of each phage.

In Lyon, the PHAGEinLYON consortium is developing phage therapy, especially in bone and joint infections. Each phage treatment requires an extemporaneous preparation performed by the hospital pharmacy. In this context, we wish to share our pharmaceutical experience.
First, the medical context of phage therapy in Lyon will be explained, as well as how hospital governance and healthcare authorities support this medical approach given the current status of phages in France.

Then, several formulations already prepared in our hospital (depending of the route of administration, i.e: intraarticular, intravenous, hydrogel application onto bone during surgery) will be presented with their intended.

Finally, quality controls and risk analysis performed for all preparations will be detailed.

Discussion forum

GERPAC provides for its members a discussion forum specifically devoted to technology in hospital pharmacy

Access forum

Association Loi 1901
Siège social : Chez Jean-Yves Jomier / 8ter rue Léon Bussat, 64000 PAU
Immatriculation formation N° 72 64 035 30 64
Contact us Legal notes - Management of personal data
Réalisation : Développeur web WordPress & SPIP freelance